To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential effect of the request for the repayment of the £370 million allocated to community pharmacies during the covid-19 outbreak on the future financial sustainability of that sector.
This answer is the replacement for a previous holding answer.
23 March 2021
Discussions are ongoing with the Pharmaceutical Services Negotiating Committee about additional funding for costs incurred during the COVID-19 pandemic. As part of its ongoing assessment of COVID-19 costs incurred by the sector the Government will take account of the £370 million increased advance payments paid to community pharmacies.
The COVID-19 support package for community pharmacy also included general COVID-19 business support, funding for Bank Holiday openings, social distancing measures and the medicine delivery service to shielded patients, free personal protective equipment and non-monetary support including the removal of some administrative tasks, flexibility in opening hours and the delayed introduction of new services.